Profile data is unavailable for this security.
About the company
Swedencare AB (publ) is a Sweden-based company which is mainly involved in the veterinary supplies industry. The company scope of activity includes manufacturing, developing and sale of products in the field of animal health care and preventive dental care products made of seaweed selected cold North Atlantic waters off the Scandinavian coastline. The Company operates as a provider of various products for animal health, distributed to veterinarians, pet stores as well as pharmacies. The Company's product portfolio includes ProDen product family, which consists of ProDen PlaqueOff Teeth and Gums, ProDen PlaqueOff Dental Bites, among others. The products are available at veterinary clinics, pet retailers, pharmacies, health stores and dentist practices.
- Revenue in SEK (TTM)2.67bn
- Net income in SEK63.00m
- Incorporated1993
- Employees609.00
- LocationSwedencare AB (publ)Per Albin Hanssons Vag 41MALMO 214 32SwedenSWE
- Phone+46 4085933
More ▼
Mergers & acquisitions
| Acquired company | SECARE:STO since announced | Transaction value |
|---|---|---|
| Summit Veterinary Pharmaceuticals Ltd | -35.26% | 54.74m |
Data delayed at least 15 minutes, as of Feb 13 2026 17:00 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cinclus Pharma Holding publ AB | 48.42m | -177.05m | 806.03m | 19.00 | -- | 1.91 | -- | 16.65 | -3.80 | -3.80 | 1.04 | 9.07 | 0.0777 | -- | 15.47 | 3,724,539.00 | -28.43 | -- | -32.01 | -- | -- | -- | -365.65 | -- | -- | -- | 0.0197 | -- | -23.14 | -- | 21.89 | -- | -- | -- |
| Vistin Pharma ASA | 427.24m | 73.33m | 883.07m | 77.00 | 12.04 | 3.01 | 9.44 | 2.07 | 1.76 | 1.76 | 10.26 | 7.05 | 1.12 | 1.87 | 6.20 | -- | 19.20 | 1.65 | 23.64 | 1.99 | 66.40 | 62.28 | 17.16 | 1.88 | 1.16 | -- | 0.063 | -- | -1.45 | 13.56 | 37.62 | -1.03 | 17.32 | -- |
| Orexo AB | 386.40m | -201.10m | 940.66m | 72.00 | -- | 1.91 | -- | 2.43 | -5.80 | 18.42 | 11.15 | 14.22 | 0.4073 | 1.29 | 2.02 | 5,366,667.00 | -21.20 | -28.03 | -29.75 | -42.57 | 89.96 | 83.88 | -52.04 | -74.89 | 3.70 | -3.00 | 0.5005 | -- | -12.46 | -47.69 | 15.63 | -- | -- | -- |
| SynAct Pharma AB | 0.00 | -106.27m | 993.01m | 8.00 | -- | 5.10 | -- | -- | -2.20 | -2.20 | 0.00 | 3.65 | 0.00 | -- | -- | 0.00 | -45.16 | -85.38 | -50.22 | -99.19 | -- | -- | -- | -- | -- | -63.96 | 0.0071 | -- | -- | -- | 61.82 | -- | -- | -- |
| Arcticzymes Technologies ASA | 96.82m | 7.19m | 1.07bn | 55.00 | 152.28 | 3.45 | 69.01 | 11.05 | 0.1464 | 0.1464 | 1.97 | 6.47 | 0.2967 | 0.295 | 1.91 | 1,874,073.00 | 2.20 | 13.28 | 2.32 | 14.39 | 95.42 | 96.20 | 7.43 | 31.41 | 15.45 | -- | 0.0184 | 0.00 | -12.26 | 18.22 | -56.40 | -- | 53.98 | -- |
| Photocure ASA | 504.98m | 1.99m | 1.60bn | 101.00 | 779.12 | 3.44 | 54.35 | 3.18 | 0.0809 | 0.0809 | 20.00 | 18.29 | 0.7587 | 1.15 | 8.11 | 5,322,683.00 | 0.2993 | -3.65 | 0.3389 | -4.19 | 92.83 | 94.00 | 0.3945 | -6.26 | 3.87 | -- | 0.00 | -- | 4.94 | 13.29 | -441.16 | -- | 65.53 | -- |
| Flerie AB | 0.00 | -757.00m | 2.68bn | 2.00 | -- | 0.7925 | -- | -- | -9.76 | -9.76 | 0.00 | 43.60 | 0.00 | -- | -- | -- | -19.86 | -18.21 | -19.95 | -18.51 | -- | -367.55 | -- | -1,314.83 | -- | -0.0489 | 0.0006 | -- | -100.00 | -- | -231.97 | -- | -- | -- |
| Swedencare AB (publ) | 2.67bn | 63.00m | 3.93bn | 609.00 | 62.13 | 0.5751 | 10.52 | 1.47 | 0.396 | 0.396 | 16.78 | 42.77 | 0.2788 | 3.63 | 9.86 | 4,776,250.00 | 0.6536 | 1.16 | 0.6795 | 1.20 | 33.60 | 36.00 | 2.34 | 4.40 | 1.52 | 3.94 | 0.2015 | 44.56 | 8.62 | 82.09 | 68.77 | 27.02 | 69.39 | 12.30 |
| BioGaia AB | 1.54bn | 332.76m | 10.21bn | 242.00 | 31.53 | 7.98 | 28.58 | 6.64 | 3.29 | 3.29 | 15.21 | 12.99 | 0.847 | -- | -- | 6,356,066.00 | 18.32 | 15.48 | 20.63 | 16.86 | 73.37 | 73.12 | 21.63 | 26.35 | -- | -- | -- | 133.18 | 8.11 | 15.54 | -5.30 | 13.11 | -25.87 | 24.01 |
| Bonesupport Holding AB | 1.12bn | 151.92m | 11.91bn | 143.00 | 79.02 | 14.44 | 73.35 | 10.64 | 2.29 | 2.29 | 16.83 | 12.52 | 1.26 | 0.6205 | 6.26 | 8,811,984.00 | 17.06 | 5.14 | 20.11 | 6.31 | 92.61 | 91.40 | 13.57 | 5.59 | 3.92 | 19.36 | 0.0133 | 0.00 | 52.05 | 42.04 | -45.41 | -- | 5.71 | -- |
| Vimian Group AB | 4.49bn | 329.66m | 14.63bn | 1.20k | 44.40 | 1.98 | 19.69 | 3.26 | 0.6265 | 0.6265 | 8.54 | 14.02 | 0.383 | 1.67 | 7.56 | -- | 2.92 | 1.42 | 3.27 | 1.62 | 68.90 | 69.18 | 7.62 | 3.96 | 1.22 | 7.96 | 0.2519 | 0.00 | 13.42 | 42.94 | 74.59 | -9.36 | 21.97 | -- |
Data as of Feb 13 2026. Currency figures normalised to Swedencare AB (publ)'s reporting currency: Swedish Krona SEK
18.90%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Handelsbanken Fonder ABas of 31 Jan 2026 | 8.40m | 5.26% |
| F�rsta AP-fondenas of 31 Dec 2024 | 6.33m | 3.96% |
| Grandeur Peak Global Advisors LLCas of 31 Dec 2024 | 2.91m | 1.82% |
| AMF Fonder ABas of 30 Jun 2025 | 2.77m | 1.73% |
| Moneta Asset Management SASas of 31 Dec 2024 | 2.27m | 1.42% |
| SEB Funds ABas of 30 Jan 2026 | 1.88m | 1.17% |
| Joh. Berenberg, Gossler & Co. KG (Investment Management)as of 31 Jan 2025 | 1.80m | 1.13% |
| Aktia Asset Management Ltd.as of 31 Dec 2024 | 1.56m | 0.98% |
| Deka Investment GmbHas of 30 Apr 2025 | 1.19m | 0.75% |
| Montanaro Asset Management Ltd.as of 31 Dec 2025 | 1.10m | 0.69% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
